Skip to main content
OpenTrials

Clinical trial condition

Skin Manifestations

Explore clinical trials studying Skin Manifestations. Study availability and eligibility vary by location and protocol.

1,072 public trials 157 recruiting studies
Refine in advanced search Browse all conditions

Skin Manifestations trial results

Active, Not Recruiting

A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

NCT05885555

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Med Center Boston, Massachusetts, United States
  • Novartis Investigative Site CABA, Argentina
  • Novartis Investigative Site Garran, Australian Capital Territory, Australia
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

NCT04683003

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Childrens Healthcare of Atlanta Atlanta, Georgia, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Mid Ohio Heart Clinic Inc Dublin, Ohio, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)

NCT06553768

Conditions
Bile Duct Diseases, Biliary Atresia, Biliary Tract Diseases, +13 more
Locations
  • Children's Hospital Los Angeles (CHLA) Los Angeles, California, United States
  • Stanford Children's Health in Palo Alto Palo Alto, California, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

NCT05500326

Conditions
Disease Attributes, Ectoparasitic Infestations, Infections, +14 more
Locations
  • Banchieng Health Centre Kasy District, Vientiane Province, Laos
  • Hinngoon Health Centre Kasy District, Vientiane Province, Laos
  • Kasy District Hospital Kasy District, Vientiane Province, Laos
  • Poonglack Health Centre Kasy District, Vientiane, Laos
View Trial Details
Active, Not Recruiting

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

NCT06787586

Conditions
Atopic Dermatitis (AD), Atopic Eczema, Chronic Pruritus, +17 more
Locations
  • Attovia Clinical Site 103 Encinitas, California, United States
  • Attovia Clinical Site 116 Rocklin, California, United States
  • Attovia Clinical Site 107 Sacramento, California, United States
  • Attovia Clinical Site 109 Coral Gables, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
  • The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States
View all 155 locations
View Trial Details
Active, Not Recruiting

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +13 more
Locations
  • Investigative Site 118 Birmingham, Alabama, United States
  • Investigative Site 108 Little Rock, Arkansas, United States
  • Investigative Site 105 San Diego, California, United States
  • Investigative Site 116 Tampa, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

NCT05046717

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Centro Hospitalar e Universitario de Coimbra Coimbra, Coimbra District, Portugal
  • Complejo Hospitalario Universitario A Coruña A Coruña, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details

Related conditions